LM Advisors’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.56M Buy
22,350
+18,794
+529% +$2.8M 0.41% 48
2026
Q1
$24.3K Sell
3,556
-375
-10% -$57.8K 0.38% 59
2025
Q4
$25.4K Sell
3,931
-21,074
-84% -$3.16M 0.46% 55
2025
Q3
$3.48M Buy
25,005
+330
+1% +$44.7K 0.5% 42
2025
Q2
$3.33M Sell
24,675
-1,992
-7% -$269K 0.43% 39
2025
Q1
$3.89M Sell
26,667
-1,233
-4% -$179K 0.7% 27
2024
Q4
$3.84M Buy
27,900
+689
+3% +$101K 0.69% 29
2024
Q3
$4.19M Sell
27,211
-1,459
-5% -$221K 0.85% 25
2024
Q2
$4.18M Sell
28,670
-1,275
-4% -$183K 0.74% 26
2024
Q1
$4.42M Buy
29,945
+1,383
+5% +$198K 0.7% 27
2023
Q4
$3.9M Buy
+28,562
New +$3.72M 0.78% 24

Other funds holding XLV

LM Advisors's XLV Position: Q2 2026 in Review

LM Advisors increased its State Street Health Care Select Sector SPDR ETF (XLV) stake by 529% in Q2 2026, buying an estimated $2.8M and bringing the position to 22,350 shares worth $3.56M. The position accounts for 0.41% of the portfolio, ranked #48.

LM Advisors first reported a position in XLV in Q4 2023 and has held it in 11 quarters since. The position peaked at $4.42M in Q1 2024. 1,853 funds tracked by Wall St. Rank hold XLV as of Q2 2026.

  • LM Advisors held 22,350 shares of State Street Health Care Select Sector SPDR ETF worth $3.56M as of Q2 2026.
  • LM Advisors bought 18,794 State Street Health Care Select Sector SPDR ETF shares in Q2 2026, an estimated $2.8M.
  • State Street Health Care Select Sector SPDR ETF made up 0.41% of LM Advisors's portfolio in Q2 2026, its #48 holding.
  • LM Advisors first reported a position in State Street Health Care Select Sector SPDR ETF in Q4 2023 and has held it in 11 quarters since.
  • LM Advisors's State Street Health Care Select Sector SPDR ETF position peaked at $4.42M in Q1 2024.
  • 1,853 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q2 2026.

Based on LM Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.